A novel Schiff base, benzylmethyl-4-methyl-3-thiosemicarbazone (BMM) derived from benzylmethylketone and 4-methylthiosemicarbazide was synthesized and characterized by elemental analysis, spectroscopic methods (IR, 1 H NMR, 13 C NMR) and physical means. The single crystal structure analysis of the Schiff base reveals that it crystallizes in a monoclinic system in the P2 1 /c space group. BMM revealed moderate antibacterial activity on three bacterial strains with diameter zone of inhibition of 16 mm (E. coli), 14 mm (K. pneumonia) and 13 mm (S. epidermidis) compared with the standard drug, ciprofloxacin.
Introduction
Benzylmethylketone, also known as phenyl-2-propanone occurs as a metabolite of amphetamine via oxidative deamination. It is used as an intermediate in the production of pesticides, rodenticides and anticoagulants [1] . On the other hand, thiosemicarbazones are useful in the medicinal and pharmaceutical fields because of their great significant pharmacological properties such as antibacterial [2] [3] [4] , antifungal [2] , anti-HIV [5] [6] , anticancer [7] [8], antineoplastic [9] , anti-inflammatory [10] , tuberclostatic [11] and their variable bonding nature. The biological activities of thiosemicarbazones often depend on the parent aldehyde or ketone. In recent years, we have been working on the synthesis of heterocyclic thiosemicarbazone, their metal complexes and biological activities [12] [13] . As part of our ongoing studies, in this paper, we describe synthesis, IR, NMR and single crystal X-ray structure of BMM. The antibacterial studies of the novel Schiff base were carried out against: Staphylococcus epidermidis, Bacillus cereus, Escherichi coli and Klebsiella pneumoniae.
Experimental

Materials
Benzylmethylketone, 4-methylthiosemicarbazide, ethanol and acetic acid were used as purchased without further purification. Elemental analysis was performed on a VARIO EL (Heraeus) analyzer. IR spectrum was obtained from a Perkin-Elmer System 2000 FT-IR spectrophotometer using KBr pellets. The mass spectrum (ESI) was recorded with an FT-IR (APEX II) mass spectrometer from Bruker Daltonics and NMR spectra were run in CD 3 COCD 3 on a 400 MHz spectrometer. Melting point was recorded on a Gallen-Kamp melting point apparatus and is uncorrected. Elemental analysis was performed on a Thermo Flash EA-1112 Series CHNS-O Elemental Analyzer.
Synthesis of Benzylmethyl-4-Methyl-3-Thiosemicarbazone (BMM)
A suspension of 4-methylthiosemicarbazide (210 mg, 0.002 mol) dissolved in 15 ml ethanol was added to a solution of benzylmethylketone (0.27 mL, 0.002 mol).
Five (05) drops of glacial acetic acid were added to the mixture. The reaction mixture (colourless) was allowed to reflux for 6 hours (Scheme 1) at a temperature of 70˚C. The yellowish filtrate which was allowed to cool, formed suitable crystals for X-ray diffraction studies. 
Single Crystal X-Ray Diffraction Analysis and Structure Determination
This was performed using standard procedures as reported by Nfor et al. [14] .
Briefly, suitable-single crystal of BMM was mounted in air unto a loop. The data collection for BMM was carried out with a Bruker DUO APEX II CCD diffractometer at temperature controlled using an Oxford cryostream-700. Data reduction and cell refinement were performed using SAINT-Plus, and the space group was determined from systematic absences by XPREP and further justified by the refinement results. Graphite monchromated MoKα (λ = 0.71073 Å) radiation was used. The X-ray diffraction data have corrected for Lorentz-polarization factor and scaled for absorption effects by multi-scan using SADABS. The struc-ture was solved by direct method, implemented in SHELXS-97. Refinement procedure by full-matrix least-square method based on P 2 values against reflections have been performed by SHELX-97, including anisotropic displacement parameters for all non-H atoms. The positions of hydrogen atoms belonging to the carbon atoms were geometrically optimized by applying a riding model. Calculations concerning the molecular geometry, the affirmation of chosen space groups and the analysis of hydrogen bonds were performed with PLATON. The molecular graphic was done with ORTEP-3 and Mercury (version 3.0).
Antimicrobial Activity
The antibacterial activity of the BMM was determined using a modified KirbyBauer disc diffusion method [15] . 
Results and Discussion
The condensation reaction between benzylmehtylketone and 4-methylthiosemicarbazide gave benzylmethyl-4-methyl-3-thiosemcarbazone in good yield (Scheme 1).
Elemental Analyses
The elemental analysis for C, H, N and S revealed that the calculated and experimental data for the Schiff base are in good agreement suggesting the high percent purity of the compound which was further confirmed by mass spectrometry.
Infrared Spectrum
The infrared spectrum ( 
1 H NMR Spectrum
The 1 H NMR spectrum ( Figure S1 ) of benzylmethyl-4-methyl-3-thiosemcarbaScheme 
13 C NMR Spectrum
The 13 C NMR spectrum ( Figure S2 ) of benzylmethyl-4-methyl-3-thiosemcarbazone was recorded in CD 3 COCD 3 . The most deshielded peak appeared at 179.9
ppm and was attributed to C=S, followed by a peak at 150.5 ppm which was assigned to C=N. Signals for the aromatic carbon atoms were observed in the range, 137.3 -126.7 ppm while the methylene carbon atom directly attached to the aromatic ring was seen at 44.7 ppm.
Single Crystal X-Ray Crystallography
The molecular structure of the Schiff base is shown in Figure 2 
Antimicrobial Activity of Benzylmethyl-4-Methyl-3-Thiosemcarbazone (BMM)
The antibacterial activity of BMM as shown on Table 1 .
BMM was found to be moderately active against three strains of bacteria. The involve the formation of hydrogen bond through azomethine group with the active centre of the cell constituents, thereby resulting in the interference with normal cell processes [17] . This is the first report of benzylmethyl-4-methyl-3-thiosemicarbazone on bacteria. Given the promiscuity of thiosemicarbazones, BMM will be screened on other pathogens such as malaria and onchocerciasis.
Conclusion
A novel compound, benzylmethyl-4-methyl-3-thiosemcarbazone (BMM) de- coli), 14 mm (K. pneumonia) and 13 mm (S. epidermidis) for the first time, suggesting that such compounds could be exploited as antibacterial leads. In vivo screening and toxicity studies will be done to ascertain its possibility as a lead for drug or prodrug development.
